Karin Hellgren

About me
Publications
CV
Public outreach and news

Research

[pubmed:20155827]
[pubmed:19439429]
[pubmed:22294058]
[pubmed:20405111]

Articles

Article: JOURNAL OF INTERNAL MEDICINE. 2025;297(5):505-517
Non-steroidal anti-inflammatory drugs and risk of kidney cancer: A Swedish nationwide cohort study in the general and high-use populations
Wadstrom H; Askling J; Gedeborg R; Feltelius N; Hellgren K
Article: RHEUMATOLOGY. 2025;64(1):117-125
Hydroxychloroquine in lupus or rheumatoid arthritis pregnancy and risk of major congenital malformations: a population-based cohort study
Nguyen NV; Svenungsson E; Dominicus A; Altman M; Hellgren K; Simard JF; Arkema EV
Article: JOURNAL OF INTERNAL MEDICINE. 2024;296(4):336-349
Impact of cancer on the mortality of patients with idiopathic inflammatory myopathies by flexible parametric multistate modelling
Che WI; Kuja-Halkola R; Hellgren K; Lundberg IE; Westerlind H; Baecklund F; Holmqvist M
Article: RMD OPEN. 2023;9(3):e003438
Association of childhood infections and perinatal factors with ankylosing spondylitis: a Swedish nationwide case-control and sibling study
Morin M; Hellgren K; Lindstroem U; Frisell T
Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(8):1445-1455
Familial Co-Aggregation of Idiopathic Inflammatory Myopathies and Cancer: A Swedish Population-Based Study
Che WI; Baecklund F; Hellgren K; Kuja-Halkola R; Lundberg IE; Westerlind H; Holmqvist M
Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(7):911-919
Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study
Huss V; Bower H; Hellgren K; Frisell T; Askling J; ARTIS G
Article: LANCET RHEUMATOLOGY. 2023;5(3):E121-E129
Temporal trends in adverse pregnancy outcomes in axial spondyloarthritis in Sweden: a cohort study.
Morin M; Frisell T; Stephansson O; Hellgren K
Article: RMD OPEN. 2023;9(1):e002924
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers
Delcoigne B; Kopp TI; Arkema EV; Hellgren K; Provan SA; Relas H; Aaltonen K; Trokovic N; Gudbjornsson B; Grondal G; Klami Kristianslund E; Lindhardsen J; Dreyer L; Askling J
Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(2):200-211
Familial autoimmunity in patients with idiopathic inflammatory myopathies
Che WI; Westerlind H; Lundberg IE; Hellgren K; Kuja-Halkola R; Holmqvist ME
Article: RMD OPEN. 2022;8(2):e002776
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study
Cordtz RL; Askling J; Delcoigne B; Smedby KE; Baecklund E; Ballegaard C; Isomaki P; Aaltonen K; Gudbjornsson B; Love TJ; Provan SA; Michelsen B; Sexton J; Dreyer L; Hellgren K
Article: RMD OPEN. 2022;8(2):e002445
Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and Denmark
Secher AEP; Granath F; Glintborg B; Rom A; Hetland ML; Hellgren K
Article: RHEUMATOLOGY. 2022;61(9):3711-3722
Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark
Hellgren K; Secher AE; Glintborg B; Rom AL; Gudbjornsson B; Michelsen B; Granath F; Hetland ML
Article: ARTHRITIS & RHEUMATOLOGY. 2022;74(3):486-495
Pregnancy Outcomes in Women With Psoriatic Arthritis In Relation To Presence and Timing of Antirheumatic Treatment
Remaeus K; Johansson K; Granath F; Stephansson O; Hellgren K
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2022;51(1):10-20
Is family history a predictor of response to tumour necrosis factor inhibitors in spondyloarthritis? A Swedish nationwide cohort study
Morin M; Hellgren K; Lindstrom U; Frisell T
Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1461-1466
Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies
Che WI; Westerlind H; Lundberg IE; Hellgren K; Kuja-Halkola R; Holmqvist M
Article: JOURNAL OF RHEUMATOLOGY. 2021;48(10):1512-1518
Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis
Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Peltomaa R; Aaltonen K; Trokovic N; Kristianslund EK; Kvien TK; Provan SA; Gudbjornsson B; Grondal G; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson LTH; Askling J
Article: RHEUMATOLOGY. 2021;60(8):3656-3668
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study
Hellgren K; Ballegaard C; Delcoigne B; Cordtz R; Nordstrom D; Aaltonen K; Gudbjornsson B; Love TJ; Provan SA; Sexton J; Zobbe K; Kristensen LE; Askling J; Dreyer L
Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021;51(1):331-337
Overall and site-specific cancer before and after diagnosis of idiopathic inflammatory myopathies: A nationwide study 2002-2016
Dani L; Che WI; Lundberg IE; Hellgren K; Holmqvist M
Article: RHEUMATOLOGY. 2021;60(2):809-819
Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype
Hellgren K; Di Giuseppe D; Smedby KE; Sundstrom C; Askling J; Baecklund E
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020;52(5):843-854
Paediatric infections in the first 3 years of life after maternal anti-TNF treatment during pregnancy
Broms G; Kieler H; Ekbom A; Gissler M; Hellgren K; Leinonen MK; Pedersen L; Schmitt-Egenolf M; Sorensen HT; Granath F
Article: RHEUMATOLOGY. 2020;59(9):2572-2580
Pregnancy outcomes in women with idiopathic inflammatory myopathy, before and after diagnosis-a population-based study
Che WI; Hellgren K; Stephansson O; Lundberg IE; Holmqvist M
Article: JOURNAL OF RHEUMATOLOGY. 2020;47(9):1392-1396
Reproductive Pattern in Women with Idiopathic Inflammatory Myopathy: A Population-based Study
Che WI; Hellgren K; Lundberg IE; Holmqvist M
Article: RHEUMATOLOGY. 2020;59(7):1695-1702
Familial aggregation and heritability of ankylosing spondylitis - a Swedish nested case-control study
Morin M; Hellgren K; Frisell T
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29(3):316-327
Anti-TNF treatment during pregnancy and birth outcomes: Apopulation-based study from Denmark, Finland, and Sweden
Broms G; Kieler H; Ekbom A; Gissler M; Hellgren K; Lahesmaa-Korpinen A-M; Pedersen L; Schmitt-Egenolf M; Sorensen HT; Granath F
Article: BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2019;126(10):1213-1222
Maternal and infant pregnancy outcomes in women with psoriatic arthritis: a Swedish nationwide cohort study
Remaeus K; Stephansson O; Johansson K; Granath F; Hellgren K
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(12):2025-2030
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project
Mercer LK; Regierer AC; Mariette X; Dixon WG; Baecklund E; Hellgren K; Dreyer L; Hetland ML; Cordtz R; Hyrich K; Strangfeld A; Zink A; Canhao H; Victoria Hernandez M; Tubach F; Gottenberg J-E; Morel J; Zavada J; Iannone F; Askling J; Listing J
Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(4):700-708
Rheumatoid Arthritis and Risk of Malignant Lymphoma
Hellgren K; Baecklund E; Backlin C; Sundstrom C; Smedby KE; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(1):105-111
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers
Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LTH; Kristensen L-E; Feltelius N; Hetland ML; Askling J
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2016;14(2):234-41.e1-5-241.e5
Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti-Tumor Necrosis Factor Agents During Pregnancy
Broms G; Granath F; Ekbom A; Hellgren K; Pedersen L; Sorensen HT; Stephansson O; Kieler H
Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(1):183-189
Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden
Frisell T; Hellgren K; Alfredsson L; Raychaudhuri S; Klareskog L; Askling J
Journal article: RHEUMATOLOGY. 2015;54(suppl_1):i25
O07. First Results of a European Registries Collaborative Project to Describe the Spectrum of Lymphomas Across Different Drug Treatment Groups in Rheumatoid Arthritis
Mercer L; Mariette X; Dixon W; Baecklund E; Hellgren K; Dreyer L; Hetland M; Mellemkjær L; Hyrich K; Strangfeld A; Zink A; Canhao H; Martins F; Hernández V; Tubach F; Gottenberg J-E; Morel J; Zavada J; van Riel P; Finckh A; Iannone F; Askling J; Listing J
Article: ARTHRITIS & RHEUMATOLOGY. 2014;66(5):1282-1290
Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden
Hellgren K; Smedby KE; Backlin C; Sundstrom C; Feltelius N; Eriksson JK; Baecklund E; Askling J
Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:a427
FRI0166 Does biological therapy alter the lymphoma risk or distribution of lymphoma subtypes in patients with ra?
Baecklund E; Hellgren K; Sundström C; Askling J; group AS
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2012;68(7):1033-1042
Search for the molecular basis of ultra-rapid CYP2C9-catalysed metabolism: relationship between SNP IVS8-109A>T and the losartan metabolism phenotype in Swedes
Hatta FHM; Teh LK; Hellden A; Hellgren KE; Roh H-K; Salleh MZ; Aklillu E; Bertilsson L
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2010;66(8):791-795
Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9
Hellden A; Bergman U; Hellgren KE; Masquelier M; Remahl IN; Odar-Cederlof I; Ramsjo M; Bertilsson L
Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(5):1252-1258
Do Rheumatoid Arthritis and Lymphoma Share Risk Factors? A Comparison of Lymphoma and Cancer Risks Before and After Diagnosis of Rheumatoid Arthritis
Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(4):654-659
Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study
Hellgren K; Iliadou A; Rosenquist R; Feltelius N; Backlin C; Enblad G; Askling J; Baecklund E
Show more

All other publications

Review: LUPUS SCIENCE & MEDICINE. 2024;11(1):e001106
Prevalence of coeliac disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis
Sotoodeh A; Hoang MN; Hellgren K; Forss A
Conference publication: 2023;:a22.1-a2a22
LO-026 Hydroxychloroquine use in pregnant women with systemic lupus erythematosus and major congenital malformations in the offspring
Nguyen VN; Svenungsson E; Dominicus A; Hellgren K; Simard JF; Arkema E
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:231-232
CHILDHOOD INFECTIONS AND PERINATAL FACTORS AS RISK FACTORS FOR ANKYLOSING SPONDYLITIS - RESULTS FROM A NATIONWIDE CASE-CONTROL STUDY
Morin M; Lindstrom U; Hellgren K; Frisell T
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:924-925
DIAGNOSTIC CHALLENGES IN A PREGNANT PATIENT WITH SLE AND SYSTEMIC SCLEROSIS OVERLAP - PREECLAMPSIA, ACTIVE LUPUS NEPHRITIS OR RENAL CRISIS?
Gheorghe K; Hellgren K; Gunnarsson K
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:890
HYDROXYCHLOROQUINE USE IN PREGNANT WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND MAJOR CONGENITAL MALFORMATIONS IN THE OFFSPRING
Nguyen NV; Svenungsson E; Dominicus A; Hellgren K; Simard J; Arkema E
Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(2):415-416
FAMILIAL ASSOCIATIONS OF AUTOIMMUNE DISEASES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES - A SWEDISH POPULATION-BASED STUDY
Che WI; Westerlind H; Lundberg IE; Hellgren K; Kuja-Halkola R; Holmqvist M
Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(2):435
CLUSTERING OF CANCERS IN FAMILIES OF IDIOPATHIC INFLAMMATORY MYOPATHIES: ASSOCIATIONS VARY BY CLINICAL PHENOTYPE AND SEX
Che WI; Baecklund F; Hellgren K; Kuja-Halkola R; Lundberg IE; Westerlind H; Holmqvist M
Letter: ARTHRITIS & RHEUMATOLOGY. 2022;74(10):1720-1721
Untitled Reply
Remaeus K; Johansson K; Granath F; Stephansson O; Hellgren K
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:41
EXPOSURE TO SPECIFIC TUMOR NECROSIS FACTOR INHIBITORS AND RISK OF DEMYELINATING AND INFLAMMATORY NEUROPATHY IN PATIENTS WITH INFLAMMATORY ARTHRITIS. A COLLABORATIVE OBSERVATIONAL STUDY ACROSS FIVE NORDIC RHEUMATOLOGY REGISTERS
Delcoigne B; Kopp TI; Arkema E; Hellgren K; Provan SA; Relas H; Aaltonen K; Trokovic N; Gudbjornsson B; Grondal G; Kristianslund E; Dreyer L; Askling J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:81-82
ARE WOMEN WITH SPONDYLOARTHRITIS AT INCREASED RISK OF ADVERSE MATERNAL AND INFANT OUTCOMES? - A SWEDISH COHORT STUDY
Morin M; Frisell T; Stephansson O; Hellgren K
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:169-170
RISK OF HAEMATOLOGICAL MALIGNANCY IN PATIENTS WITH PSORIATIC ARTHRITIS, OVERALL AND IN RELATION TO TNF INHIBITORS - A NORDIC COHORT STUDY
Cordtz R; Askling J; Delcoigne B; Smedby KE; Baecklund E; Ballegaard C; Isomaki P; Aaltonen K; Gudbjornsson B; Love T; Provan SA; Michelsen B; Sexton J; Dreyer L; Hellgren K
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:1618
IMPACT OF A FAMILY HISTORY OF SPONDYLOARTHRITIS ON TNFI DRUG SURVIVAL AND TREATMENT RESPONSE IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS
Morin M; Hellgren K; Lindstrom U; Frisell T
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019;28:10
Infant Infections after Maternal Anti-TNF Treatment in Pregnancy
Broms G; Kieler H; Ekbom A; Gissler M; Hellgren K; Leinonen MK; Pedersen L; Schmitt-Egenolf M; Sorensen HT; Granath F
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:703-704
EFFECTIVENESS OF TNF INHIBITORS VS. NON-TNF INHIBITORS (ABATACEPT, TOCILIZUMAB AND RITUXIMAB) AFTER FAILURE OF NON-TNFI BIOLOGIC DMARD IN RHEUMATOID ARTHRITIS - COLLABORATION BETWEEN FIVE NATIONAL REGISTERS
Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Aaltonen K; Trokovic N; Kristianslund E; Kvien TK; Provan SA; Gudbjornsson B; Grondal G; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson LTH; Askling J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:866-867
TOWARDS MORE PRECISE ESTIMATES OF THE FAMILIAL AGGREGATION AND HERITABILITY OF ANKYLOSING SPONDYLITIS - A SWEDISH NESTED CASE-CONTROL STUDY
Morin M; Hellgren K; Frisell T
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:67-68
INCIDENCE OF OVERALL AND SITE-SPECIFIC CANCERS IN TNF INHIBITOR TREATED PATIENTS WITH PSORIATIC ARTHRITIS: A POPULATION-BASED COHORT STUDY FROM 4 NORDIC COUNTRIES
Ballegaard C; Hellgren K; Cordtz R; Delcoigne B; Gudbjornsson B; Love TJ; Aaltonen K; Nordstrom D; Provan SA; Askling J; Zobbe K; Kristensen LE; Dreyer L
Review: RMD OPEN. 2018;4(1):e000655
Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example
Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Aaltonen K; Tormanen MRK; Kristianslund EK; Kvien TK; Provan SA; Guobjornsson B; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson L; Askling J
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67
Lymphoma in Patients with Rheumatoid Arthritis Treated with Biologic Drugs: Long-Term Follow-up of Risks and Lymphoma Subtypes
Hellgren K; Sundstrom C; Askling J; Baecklund E
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2014;66:S806-S807
First Results of a European Registries Collaborative Project to Compare the Spectrum of Lymphomas Between Different Exposure Groups in Rheumatoid Arthritis
Mercer L; Mariette X; Dixon W; Baecklund E; Hellgren K; Dreyer L; Hetland ML; Mellemkjaer L; Hyrich K; Strangfeld A; Zink A; Canhao H; Martins F; Hernandez V; Tubach F; Gottenberg J-E; Morel J; Zavada J; van Riel P; Finckh A; Iannone F; Askling J; Listing J
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:519-520
WHAT IS THE PREDICTIVE VALUE OF A FAMILY HISTORY OF ARTHRITIS-RELATED CONDITIONS ON THE RISK OF RHEUMATOID ARTHRITIS, AND DOES IT DIFFER BETWEEN SEROPOSITIVE AND SERONEGATIVE DISEASE?
Frisell T; Hellgren K; Askling J
Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2014;43:16
What is the predictive value of a family history of arthritis-related conditions on the risk of rheumatoid arthritis, and does it differ between seropositive and seronegative disease?
Frisell T; Hellgren K; Askling J
Doctoral thesis: 2013
Chronic inflammation, anti-inflammatory treatment and risk of malignant lymphomas
Hellgren K
Show more

Employments

Affiliated to Research, Department of Medicine, Karolinska Institutet, 2023-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2013
University Medical Degree, Karolinska Institutet, 1996

Research

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI